CpG motifs in bacterial DNA trigger direct B-cell activation (Q34307394)

1 August 2017

title

CpG motifs in bacterial DNA trigger direct B-cell activation (English)

1 reference

1 August 2017

Krieg AM

1

1 reference

1 August 2017

Yi AK

2

1 reference

1 August 2017

Matson S

3

1 reference

1 August 2017

Waldschmidt TJ

4

1 reference

1 August 2017

Bishop GA

5

1 reference

1 August 2017

Teasdale R

6

1 reference

1 August 2017

Koretzky GA

7

1 reference

1 August 2017

Klinman DM

8

1 reference

1 August 2017

language of work or name

English

0 references

publication date

1 April 1995

1 reference

1 August 2017

1 reference

1 August 2017

volume

374

1 reference

1 August 2017

issue

6522

1 reference

1 August 2017

page(s)

546-549

1 reference

Subversion of the immune system by pathogens.

1 August 2017

cites work

1 reference

7 January 2021

DNA binding to human leukocytes. Evidence for a receptor-mediated association, internalization, and degradation of DNA

1 reference

7 January 2021

Comparison of cellular binding and uptake of antisense phosphodiester, phosphorothioate, and mixed phosphorothioate and methylphosphonate oligonucleotides.

1 reference

7 January 2021

Binding properties of human anti-DNA antibodies to cloned human DNA fragments

1 reference

7 January 2021

Evidence for impaired T cell DNA methylation in systemic lupus erythematosus and rheumatoid arthritis

1 reference

7 January 2021

Pervasive CpG suppression in animal mitochondrial genomes

1 reference

7 January 2021

Selection of antisense oligonucleotides on the basis of genomic frequency of the target sequence.

1 reference

7 January 2021

Therapeutic Applications of Oligonucleotides

1 reference

7 January 2021

Current concepts in antisense drug design

1 reference

7 January 2021

Antisense oligonucleotides as therapeutic agents--is the bullet really magical?

1 reference

7 January 2021

Systemic human antisense therapy begins

1 reference

7 January 2021

GEM 91--an antisense oligonucleotide phosphorothioate as a therapeutic agent for AIDS

1 reference

7 January 2021

Systemic administration of a phosphorothioate oligonucleotide with a sequence complementary to p53 for acute myelogenous leukemia and myelodysplastic syndrome: initial results of a phase I trial

1 reference

7 January 2021

Antisense oligodeoxynucleotide phosphorothioate complementary to Gag mRNA blocks replication of human immunodeficiency virus type 1 in human peripheral blood cells

1 reference

7 January 2021

Gene inhibition using antisense oligodeoxynucleotides

1 reference

7 January 2021

Problems in interpretation of data derived from in vitro and in vivo use of antisense oligodeoxynucleotides

1 reference

7 January 2021

Nonspecific Suppression of [3H]Thymidine Incorporation by "Control" Oligonucleotides

1 reference

7 January 2021

B cell helper factors. I. Requirement for both interleukin 2 and another 40,000 mol wt factor

1 reference

7 January 2021

Frequency of B lymphocytes responsive to anti-immunoglobulin

1 reference

7 January 2021

Lymphocyte stimulation: a rapid multiparameter analysis

1 reference

7 January 2021

Pharmacokinetics, biodistribution, and stability of oligodeoxynucleotide phosphorothioates in mice

1 reference

7 January 2021

Identifiers

DOI

10.1038/374546A0

1 reference

Dimensions Publication ID

1 August 2017

1034049921

0 references

1 reference